β¨ Medicines Consent Notices
834 NEW ZEALAND GAZETTE No. 33
Note: This consent is valid for 2 years from the 25th day of February 1999.
Dated this 11th day of March 1999.
GILLIAN GREW, Chief Advisor, Regulation and Safety (Acting), pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go2081
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Pseudoephedrine hydrochloride 60mg | Capsule, liquid filled | R P Scherer Holdings Pty Limited, Braeside, Victoria, Australia | Dimetapp Sinus Liquid Caps |
| Triamcinolone acetonide 0.1%w/w | Paste, topical | Taro Pharmaceuticals Inc., Bramelea, Ontario, Canada | Oracort |
| Aciclovir 5%w/w | Ointment, topical | Taro Pharmaceuticals Inc., Bramelea, Ontario, Canada | Viraban |
Dated this 11th day of March 1999.
GILLIAN GREW, Chief Advisor, Regulation and Safety (Acting), pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go2080
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Lamotrigine 25mg | Tablet, chewable/dispersible | Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom; Glaxo Wellcome Australia Limited, Boronia, Victoria, Australia; and Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom | Lamictal |
| Lamotrigine 5mg | Tablet, chewable/dispersible | Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom; and Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom | Lamictal |
| Lamotrigine 50mg, 100mg, 200mg | Tablets, chewable/dispersible | Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom; and Glaxo Wellcome Australia Limited, Boronia, Victoria, Australia | Lamictal |
| Nimodipine 30mg | Tablet, film coated | Bayer AG., Leverkusen, Germany | Nimotop |
| Nimodipine 0.2mg/mL | Infusion, solution | Bayer AG., Leverkusen, Germany | Nimotop |
| Naltrexone hydrochloride 50mg | Tablet, film coated | Du Pont Merck Pharmaceuticals Co., Garden City, New York, United States of America | Re Via |
| Paclitaxel 6 mg/mL | Infusion, concentrate | Bristol-Caribbean Inc., Mayaguez, Puerto Rico | Taxol |
Dated this 11th day of March 1999.
GILLIAN GREW, Chief Advisor, Regulation and Safety (acting), pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go2078
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 33
NZLII —
NZ Gazette 1999, No 33
β¨ LLM interpretation of page content
π₯
Corrigendum: Consent to the Distribution of a New Medicine
(continued from previous page)
π₯ Health & Social Welfare11 March 1999
Medicines Act 1981, Abacavir sulphate, Ziagen, Glaxo Wellcome Operations
- GILLIAN GREW, Chief Advisor, Regulation and Safety (Acting)
π₯ Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare11 March 1999
Medicines Act 1981, Pseudoephedrine hydrochloride, Triamcinolone acetonide, Aciclovir, Dimetapp Sinus Liquid Caps, Oracort, Viraban
- GILLIAN GREW, Chief Advisor, Regulation and Safety (Acting)
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare11 March 1999
Medicines Act 1981, Lamotrigine, Nimodipine, Naltrexone hydrochloride, Paclitaxel, Lamictal, Nimotop, Re Via, Taxol
- GILLIAN GREW, Chief Advisor, Regulation and Safety (acting)